Showing results (291-300 of 297) with videos related to
Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 297 results.
Nature Medicine|April 25, 2018
Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancerJacqulyne P Robichaux, Yasir Y Elamin, Zhi Tan, et al.Nature Cancer|February 5, 2022
Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapseFan Yang, Samuel W Brady, Chao Tang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2018
Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLCXiuning Le, Sonam Puri, Marcelo V Negrao, et al.Science Translational Medicine|November 10, 2017
Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockersMonique B Nilsson, Huiying Sun, Lixia Diao, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 29, 2025
Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical TrialsZhaojun Wang, Yiran Fang, Xiatong Huang, et al.Med (New York, N.Y.)|August 1, 2024
Tumor microenvironment RNA test to predict immunotherapy outcomes in advanced gastric cancer: The TIMES001 trialMin Shi, Dongqiang Zeng, Huiyan Luo, et al.Cancer Cell|October 8, 2019
Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 ActivityJacqulyne P Robichaux, Yasir Y Elamin, R S K Vijayan, et al.Pageof 30